- Home
- AREN vs BDTX Comparison
AREN vs BDTX Comparison
Compare AREN & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AREN | BDTX |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.0M | 116.8M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AREN | BDTX |
|---|---|---|
| Price | $2.75 | $2.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $8.00 | ★ $9.67 |
| AVG Volume (30 Days) | 80.2K | ★ 809.4K |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 191.93 | 130.71 |
| EPS | ★ 2.62 | 0.39 |
| Revenue | ★ $16,892,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.00 | N/A |
| P/E Ratio | ★ $1.06 | $6.95 |
| Revenue Growth | ★ 27.46 | N/A |
| 52 Week Low | $1.72 | $1.49 |
| 52 Week High | $10.05 | $4.94 |
Technical Indicators
Market Signals| Indicator | AREN | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 60.50 | 53.14 |
| Support Level | $2.15 | $2.45 |
| Resistance Level | $3.17 | $2.79 |
| Average True Range (ATR) | 0.19 | 0.20 |
| MACD | 0.11 | -0.05 |
| Stochastic Oscillator | 74.77 | 26.26 |
Price Performance
Historical ComparisonAbout AREN The Arena Group Holdings Inc.
The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The company has four reportable segments: Sports & Leisure, Finance, Lifestyle, and Platform & Other. The company generates revenue from Sports & Leisure. Geographically, the company operates in United States; and Others. It generates maximum revenue from United States.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.